Andrew Huberman· PhD
So now what pharmaceutical companies have tried to do is to say okay let's block GDF-15 signaling so people don't feel like Uh and so there's this one trial that was published in the New England journal uh last year and they show as expected if you block GDF-15 with a monoconal antibbody u people don't feel as terrible and they eat a little more and they don't lose as much weight. Right? So it's basically if you're sick in the hospital, you have cancer, you're getting chemo, you don't want to eat, right? And energetically, I suspect this is the right thing to do because you're saving 10 15% of your energy budget, reallocating it for to healing